• DAPT (GSI-IX): γ-Secretase and Notch Research

  2026-08-20

  DAPT, also called GSI-IX, is a selective γ-secretase inhibitor used to study APP processing, amyloid-β production, and the Notch signaling pathway. Product-reported benchmarks include 115 nM for amyloid-β reduction and 200 nM for total γ-secretase activity inhibition in mammalian cell systems.

• Mestranol Reversibly Alters Zebrafish Microglia

  2026-08-20

  The reference study identifies mestranol as an inducer of a reversible lysosomal storage-like state in zebrafish microglia, marked by hypertrophy, impaired intracellular digestion, and suppression of lysosomal and immune transcriptional programs. Its live in vivo model separates lysosomal stress from cell loss and provides a tractable framework for studying environmental estrogen neuroimmunotoxicity.

• YM-155 Hydrochloride Workflow for Cancer Assays

  2026-08-19

  Build more informative cancer-drug response assays with YM-155 hydrochloride, a selective survivin inhibitor suited to separating growth suppression from cell killing. The workflow combines careful solution handling, time-resolved viability measurements, orthogonal apoptosis readouts, and model-aware interpretation for studies spanning NSCLC, breast cancer, and xenograft research.

• Pam3CSK4 TLR1/2 Agonist Workflow Guide

  2026-08-19

  Pam3CSK4 provides a defined TLR1/2 agonist challenge for macrophage, airway, platelet, and neuroimmune inflammation studies. This guide connects reproducible innate immune activation with the somato-autonomic reflex described in recent TRPV1 research, while emphasizing controls, timing, and troubleshooting.

• HyperScribe SP6 High Yield RNA Synthesis Kit

  2026-08-18

  The HyperScribe SP6 High Yield RNA Synthesis Kit supports high-yield, modification-ready RNA production for mechanistic studies of viral immune evasion. This article connects SP6 transcription choices with assays investigating GADD34 mRNA sequestration, stress-granule-like foci, and IRF3-dependent antiviral signaling.

• Losartan for Reproducible Cell Assays

  2026-08-18

  Learn how Losartan (SKU B1072) can help biomedical researchers separate AT1-receptor pathway effects from nonspecific cytotoxicity in vascular smooth muscle cell and related assays. This scenario-based guide covers concentration design, solvent compatibility, interpretation, and practical product-selection criteria supported by product data and current renal biology literature.

• CA-074 Me for Lysosomal Cell-Death Assays

  2026-08-17

  CA-074 Me provides a cell-permeable way to test whether intracellular cathepsin B drives lysosomal membrane permeabilization, necroptosis, or apoptosis. This guide translates recent MLKL–lysosome findings into practical imaging, inhibitor-treatment, and troubleshooting workflows.

• SB-505124 Hydrochloride for TGF-β Assays

  2026-08-17

  SB-505124 hydrochloride gives researchers a reversible way to separate ALK4/5/7-dependent signaling from downstream fibrosis and mechanobiology phenotypes. This practical guide connects Smad assays, fibroblast activation, glaucoma models, and stiffness measurements while emphasizing solvent control, timing, and interpretation limits.

• GANT61 as a GLI Inhibitor for Tumor Immune-Evasion Studies

  2026-08-16

  GANT61 is a practical GLI inhibitor for separating transcription-factor output from upstream Hedgehog signaling in cell, co-culture, and xenograft experiments. This guide translates GLI2–WNT–prostaglandin biology into assay-ready workflows, with solvent, timing, and interpretation controls that keep immune-evasion results defensible.

• Annexin V-Cy5 in Reversible Lysosomal Stress

  2026-08-15

  Lysosomal stress does not necessarily mean cellular death. This thought-leadership article explains how Annexin V-Cy5 apoptosis detection can help translational researchers separate phosphatidylserine exposure from broader microglial dysfunction in mestranol-exposed zebrafish models.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-08-14

  Use the Annexin V-Cy5 Apoptosis Kit to separate genuine apoptotic-cell signals from lysosomal stress phenotypes in rapid zebrafish microglia workflows. Its one-step, Cy5-based readout supports both flow cytometry apoptosis detection and fluorescence microscopy apoptosis analysis without making apoptosis the sole explanation for cellular dysfunction.

• Phytol for RXR Signaling: Workflow and Applications

  2026-08-14

  Build more interpretable RXR experiments with Phytol by controlling isomer identity, solvent exposure, dose, and orthogonal readouts. A polymer self-assembly study adds a useful design principle: systematically vary matrix and composition rather than assuming one solvent or formulation condition will be universally optimal.

• Rocket-Like Nanomedicine for Pancreatic Tumor Stroma

  2026-08-13

  Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that remodels pancreatic tumor stroma before delivering gemcitabine. In a pancreatic ductal adenocarcinoma mouse model, the integrated platform promoted tumor regression without evident treatment-related side effects under the reported conditions, supporting stroma normalization as an alternative to indiscriminate stromal depletion.

• Meropenem in Resistance and Sepsis Models

  2026-08-13

  Meropenem is a β-lactam antibiotic carbapenem suited to mechanistic antibacterial studies, resistance experiments, and Gram-negative infection models. This guide connects PBP biology with exposure design, assay controls, and translational interpretation rather than treating MIC as the only endpoint.

• MiR-24-3p/Sp1/PI3K Axis in Dox Heart Failure

  2026-08-12

  The reference study identifies miR-24-3p as a direct regulator of Sp1 and links its elevation to suppression of the Sp1/PI3K pathway in doxorubicin-induced heart failure. Across rat and H9c2 cardiomyocyte models, miR-24-3p silencing reduced apoptosis and oxidative stress, providing a mechanistic framework for studying myocardial injury.

15791 records 1/1053 page Next 12345 下5页 Last page